Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
399 studies found for:    pulmonary arterial hypertension | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension;   PAH WHO Group I
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
2 Not yet recruiting Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
Condition: Pulmonary Arterial Hypertension With Congenital Cardiac Shunt
Intervention: Other: Pharmacological test of pulmonary endothelial
3 Recruiting Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Procedure: Resynchronization therapy of right ventricle
4 Recruiting Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil
5 Recruiting Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
Conditions: Muscle Weakness;   Pulmonary Arterial Hypertension
Intervention:
6 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
7 Recruiting An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Patients With Exercise Induced Pulmonary Arterial Hypertension
Condition: Exercised Induced Pulmonary Arterial Hypertension
Intervention: Drug: ambrisentan
8 Recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
9 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention
10 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
11 Recruiting SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
12 Unknown  Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Fluoxetine
13 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo
14 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Arterial Hypertension (PAH) - LARIAT
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
15 Unknown  Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Carvedilol
16 Not yet recruiting The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ambrisentan plus Spironolactone;   Drug: Ambrisentan plus Placebo
17 Recruiting Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Slow-paced respiration therapy
18 Recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
Intervention:
19 Recruiting Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Primary Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Familial Primary Pulmonary Hypertension
Interventions: Drug: Diltiazem Hydrochloride;   Drug: Sugar Pill
20 Recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Conditions: Pulmonary Arterial Hypertension;   PAH
Intervention: Drug: Macitentan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years